Incadronate disodium inhibits advanced glycation end products-induced angiogenesis in vitro (Q44140894)

30 November 2017

title

Incadronate disodium inhibits advanced glycation end products-induced angiogenesis in vitro (English)

1 reference

30 November 2017

6

Seiji Kikuchi

1 reference

30 November 2017

Tamami Okamoto

1

1 reference

30 November 2017

Sho-ichi Yamagishi

2

1 reference

30 November 2017

Yosuke Inagaki

3

1 reference

30 November 2017

Shinjiro Amano

4

1 reference

30 November 2017

Masayoshi Takeuchi

5

1 reference

30 November 2017

Shigeaki Ohno

7

1 reference

30 November 2017

Akihiko Yoshimura

8

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

Biochemical and Biophysical Research Communications

30 November 2017

published in

1 reference

30 November 2017

volume

297

1 reference

30 November 2017

issue

2

1 reference

30 November 2017

page(s)

419-424

1 reference

Bisphosphonates: mechanisms of action

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902218-0

Developments in the therapeutic applications of bisphosphonates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902218-0

Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902218-0

Farnesyl pyrophosphate synthase is the molecular target of nitrogen-containing bisphosphonates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902218-0

Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902218-0

Protein prenylation: molecular mechanisms and functional consequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902218-0

Hemoglobin-AGE: a circulating marker of advanced glycosylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902218-0

Advanced glycosylation end products in patients with diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902218-0

Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902218-0

Receptor-Mediated Toxicity to Pericytes of Advanced Glycosylation End Products: A Possible Mechanism of Pericyte Loss in Diabetic Microangiopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902218-0

Advanced glycosylation end products stimulate the growth but inhibit the prostacyclin-producing ability of endothelial cells through interactions with their receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902218-0

Advanced glycation end products-driven angiogenesis in vitro. Induction of the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902218-0

Advanced glycation endproducts inhibit prostacyclin production and induce plasminogen activator inhibitor-1 in human microvascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902218-0

Advanced glycation endproducts accelerate calcification in microvascular pericytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902218-0

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902218-0

Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902218-0

Advanced glycation end products-induced apoptosis and overexpression of vascular endothelial growth factor in bovine retinal pericytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902218-0

Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902218-0

Palmitate-induced apoptosis of microvascular endothelial cells and pericytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902218-0

Upregulation of retinal vascular endothelial growth factor mRNAs in spontaneously diabetic rats without ophthalmoscopic retinopathy. A possible participation of advanced glycation end products in the development of the early phase of diabetic retino

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902218-0

The relationship between accumulation of advanced glycation end products and expression of vascular endothelial growth factor in human diabetic retinas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902218-0

Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902218-0

Immunological detection of a novel advanced glycation end-product

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902218-0

Insulin stimulates the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902218-0

Independent modes of transcriptional activation by the p50 and p65 subunits of NF-kappa B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902218-0

Critical role of the interleukin 2 (IL-2) receptor gamma-chain-associated Jak3 in the IL-2-induced c-fos and c-myc, but not bcl-2, gene induction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902218-0

Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxia-induced proliferation of endothelial cells and pericytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902218-0

PKCepsilon modulates NF-kappaB and AP-1 via mitogen-activated protein kinases in adult rabbit cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902218-0

ERK MAP kinase links cytokine signals to activation of latent HIV-1 infection by stimulating a cooperative interaction of AP-1 and NF-kappaB

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902218-0

Induction of vascular endothelial growth factor expression and hypoxia-inducible factor 1alpha protein by the oxidative stressor arsenite

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902218-0

Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902218-0

Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902218-0

Activation of the Receptor for Advanced Glycation End Products Triggers a p21 -dependent Mitogen-activated Protein Kinase Pathway Regulated by Oxidant Stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902218-0

Accumulation of bisphosphonates in the aorta and some other tissues of healthy and atherosclerotic rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902218-0

Accumulation of bisphosphonates in human artery and their effects on human and rat arterial function in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902218-0

10.1016/S0006-291X(02)02218-0

7 January 2021

Identifiers

DOI

1 reference

30 November 2017

1 reference